Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
A multilaboratory study to determine disk diffusion quality control ranges for Haemophilus influenzae ATCC 49247 and five investigational drugs was performed. Multiple lots of Haemophilus Test Medium and antibiotic disks were used for replicate testing in conformance with the recommendations of the National Committee for Clinical Laboratory Standards. Quality control disk zone diameter ranges were proposed for cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
Bale
M J
MJ
Special Microbiology, University of Iowa College of Medicine, Iowa City 52242.
Jones
R N
RN
Erwin
M E
ME
Koontz
F P
FP
Gerlach
E H
EH
Murray
P R
PR
Washington
J A
JA
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000077525:Cefdinir; D002511:Cephalosporins / Q000494:pharmacology; D016576:Fleroxacin / Q000494:pharmacology; D024841:Fluoroquinolones; D006193:Haemophilus influenzae / Q000187:drug effects*; D008826:Microbial Sensitivity Tests / Q000592:standards*; D011786:Quality Control; D015363:Quinolones / Q000494:pharmacology; D000198:Spectinomycin / Q000031:analogs & derivatives / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D024841:Fluoroquinolones; D015363:Quinolones; C054745:temafloxacin; C043267:trospectomycin; C057477:clinafloxacin; D000198:Spectinomycin; D000077525:Cefdinir; D016576:Fleroxacin